Research ArticleRESEARCH

Effect of High-Density Lipoprotein Associated Cyclosporine on Hepatic Metabolism and Renal Function

Taekrho Kim, Shellie M. Callahan, Kishor M. Wasan and Lane J. Brunner
PDA Journal of Pharmaceutical Science and Technology September 2003, 57 (5) 341-350;

Article Information

vol. 57 no. 5 341-350
PubMed 
14677627
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online September 1, 2003.
Copyright & Usage 
Copyright © Parenteral Drug Association. All rights reserved.

Author Information

  1. Taekrho Kim1,
  2. Shellie M. Callahan1,
  3. Kishor M. Wasan2 and
  4. Lane J. Brunner1
  1. 1Pharmaceutics Division, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712
  2. 2Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
  1. Address correspondence to:
    Lane J. Brunner, Ph. D., The University of Texas at Austin, College of Pharmacy, PHR 4.214E, 1 University Station A-1920, Austin, TX 78712-1074,
    Telephone: (512) 471-0942, Fax: (512) 471-7474, E-mail: lane.brunner{at}mail.utexas.edu

Cited By...

Back to top

In This Issue

Download PDF
Article Alerts
Email Article
Citation Tools
Effect of High-Density Lipoprotein Associated Cyclosporine on Hepatic Metabolism and Renal Function
Taekrho Kim, Shellie M. Callahan, Kishor M. Wasan, Lane J. Brunner
PDA Journal of Pharmaceutical Science and Technology Sep 2003, 57 (5) 341-350;
Twitter logo Facebook logo Mendeley logo

Jump to section